Loading clinical trials...
Loading clinical trials...
A Single-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of LY3074828 in Japanese and Caucasian Healthy Subjects
Conditions
Interventions
Mirikizumab - IV
Mirikizumab - SC
+2 more
Locations
1
United States
WCCT Global
Cypress, California, United States
Start Date
December 2, 2015
Primary Completion Date
July 16, 2018
Completion Date
October 24, 2018
Last Updated
February 8, 2024
NCT00104325
NCT07470866
NCT07388667
NCT07221448
NCT06637865
NCT07118891
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions